$IMRX 4 SEC Filings

Filed On	Filing
17 Jul 2026	Form 4: Gengos Andrew, Chief Financial Officer Granted 650,000 Stock Option
24 Jun 2026	Form 4: Zeskind Benjamin J., Director Bought 2,400 shares ($10.9K)
16 Jun 2026	Form 4: Hall Brett Matthew, CHIEF SCIENTIFIC OFFICER Bought 6,035 shares ($25K)
11 Jun 2026	Form 4: Schall Thomas J., Director Granted 33,350 Stock Option
11 Jun 2026	Form 4: Hausman Diana, Director Granted 33,350 Stock Option
11 Jun 2026	Form 4: Keating Laurie, Director Granted 33,350 Stock Option
11 Jun 2026	Form 4: Carpenter Robert J, Director Granted 33,350 Stock Option
11 Jun 2026	Form 4: Feinberg Peter, Director Granted 33,350 Stock Option
17 Mar 2026	Form 4: Neufeld Leah R, CHIEF PEOPLE OFFICER Received 3,628 shares as a grant or award ($15.6K)
05 Feb 2026	Form 4: Brakewood Harold Eugene, Chief Business Officer Granted 140,000 Stock Option
05 Feb 2026	Form 4: Bookman Michael, CHIEF LEGAL OFFICER, SECRETARY Granted 176,000 Stock Option
05 Feb 2026	Form 4: Hall Brett Matthew, CHIEF SCIENTIFIC OFFICER Granted 344,000 Stock Option
05 Feb 2026	Form 4: Matushansky Igor, Chief Medical Officer Granted 140,000 Stock Option
05 Feb 2026	Form 4: Morales Mallory, SVP Finance, CAO Granted 140,000 Stock Option
05 Feb 2026	Form 4: Neufeld Leah R, CHIEF PEOPLE OFFICER Granted 140,000 Stock Option
05 Feb 2026	Form 4: Zeskind Benjamin J., Director Granted 688,000 Stock Option
21 Jan 2026	Form 4: Brakewood Harold Eugene, Chief Business Officer Bought 5,250 shares ($25K)
20 Jan 2026	Form 4: Schall Thomas J., Director Bought 21,645 shares ($101K)
16 Jan 2026	Form 4: Hall Brett Matthew, CHIEF SCIENTIFIC OFFICER Bought 2,298 shares ($10.5K)
15 Jan 2026	Form 4: Neufeld Leah R, CHIEF PEOPLE OFFICER Bought 2,626 shares ($10.9K)

Comments